1. Name and Address of Reporting Person* 452 5TH AVENUE | 21ST FLOOR | (Street) | 2. Issuer Name and Ticker or Trading Symbol AZIYO BIOLOGICS, INC. [ AZYO ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X | Director | X | 10% Owner | | Officer (give title below) | | Other (specify below) | | |
3. Date of Earliest Transaction (Month/Day/Year) 06/07/2021 |
4. If Amendment, Date of Original Filed (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) | Form filed by One Reporting Person | X | Form filed by More than One Reporting Person | |
1. Name and Address of Reporting Person* 452 5TH AVENUE | 21ST FLOOR | (Street) |
1. Name and Address of Reporting Person* 452 5TH AVENUE | 21ST FLOOR | (Street) |
1. Name and Address of Reporting Person*HIGHCAPE PARTNERS QP, L.P. | 452 5TH AVENUE | 21ST FLOOR | (Street) |
1. Name and Address of Reporting Person*HighCape Partners GP, LLC | 452 5TH AVENUE | 21ST FLOOR | (Street) |
1. Name and Address of Reporting Person*HighCape Partners GP, L.P. | 452 5TH AVENUE | 21ST FLOOR | (Street) |
1. Name and Address of Reporting Person*HighCape Co-Investment Vehicle I, LLC | 452 5TH AVENUE | 21ST FLOOR | (Street) |
1. Name and Address of Reporting Person*HighCape Co-Investment Vehicle II, LLC | 452 5TH AVENUE | 21ST FLOOR | (Street) |
1. Name and Address of Reporting Person* 452 5TH AVENUE | 21ST FLOOR | (Street) |
1. Name and Address of Reporting Person* 452 5TH AVENUE | 21ST FLOOR | (Street) |
1. Name and Address of Reporting Person* 452 5TH AVENUE | 21ST FLOOR | (Street) |
| /s/ Kevin L. Rakin | 06/09/2021 |
| /s/ W. Matthew Zuga | 06/09/2021 |
| HighCape Partners GP, LLC<br> By: /s/ W. Matthew Zuga, Managing Member | 06/09/2021 |
| HighCape Partners GP, L.P.<br> By: /s/ W. Matthew Zuga, Managing Member | 06/09/2021 |
| HighCape Partners, L.P.<br> By: /s/ HighCape Partners GP, L.P., its general partner By: HighCape Partners GP, LLC, its general partner By: /s/ W. Matthew Zuga, Managing Member | 06/09/2021 |
| HighCape Partners QP, L.P.<br> By: /s/ HighCape Partners GP, L.P., its general partner By: HighCape Partners GP, LLC, its general partner By: /s/ W. Matthew Zuga, Managing Member | 06/09/2021 |
| HighCape Capital, L.P.<br> By: /s/ W. Matthew Zuga, Managing Member | 06/09/2021 |
| HighCape Capital, LLC<br> By: /s/ W. Matthew Zuga | 06/09/2021 |
| HighCape Co-Investment Vehicle I, LLC<br> By: /s/ HighCape Partners GP, L.P., its general partner By: HighCape Partners GP, LLC, its general partner By: /s/ W. Matthew Zuga, Managing Member | 06/09/2021 |
| HighCape Co-Investment Vehicle II, LLC<br> By: /s/ HighCape Partners GP, L.P., its general partner By: HighCape Partners GP, LLC, its general partner By: /s/ W. Matthew Zuga, Managing Member | 06/09/2021 |
| ** Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). |
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |